WebDisclosure WebDisclosure
Basculer en Français
10305 Companies
213581 Keywords
143259 Articles
113043 Press releases
Headlines Articles Press releases OptAI Inc. Remove
  1. Home
  2. Companies
  3. OptAI Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/12/2025 at 04:15, 5 months 17 days ago

    OptAI Secures CES 2026 Innovation Award for OptHancer™

    Global Expansion AI Optimization CES 2026 OptAI OptHancer™
  • BRIEF

    published on 11/12/2025 at 04:15, 5 months 17 days ago

    OptAI remporte le prix de l'innovation CES 2026 pour OptHancer™

    Expansion Mondiale Optimisation Par IA CES 2026 OptAI OptHancer™
  • PRESS RELEASE

    published on 11/12/2025 at 04:10, 5 months 17 days ago

    OptAI Wins CES 2026 Innovation Award for its AI Optimization Solution, OptHancer™

    OptAI wins CES 2026 Innovation Award for its AI Optimization Solution, OptHancer™, showcasing 'Any Model, Any Device' vision for on-device AI optimization
    AI Optimization On-Device AI OptAI CES 2026 Innovation Award OptHancer
    Logo of OptAI Inc.
Accesswire
  • Published on 04/29/2026 at 04:50, 19 minutes ago

    Alaska Energy Metals Extends Marketing Services Engagement

  • Published on 04/29/2026 at 02:25, 2 hours 44 minutes ago

    Organto Foods Announces Fiscal 2025 Financial Results

  • Published on 04/29/2026 at 01:30, 3 hours 39 minutes ago

    First Helium Announces Private Placement

  • Published on 04/29/2026 at 00:20, 4 hours 49 minutes ago

    Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2025

  • Published on 04/29/2026 at 00:00, 5 hours 9 minutes ago

    LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules

View all ACCESSWIRE
EQS Group
  • Published on 04/28/2026 at 22:15, 6 hours 54 minutes ago

    Preliminary figures confirmed by final financial statements 2025

  • Published on 04/28/2026 at 21:55, 7 hours 14 minutes ago

    Piramal Pharma Limited Announces Results for Q4 and Full-year FY26

  • Published on 04/28/2026 at 21:00, 8 hours 9 minutes ago

    VAT Group AG Annual General Meeting 2026: Shareholders approved all Board proposals and a dividend increase of 12% to CHF 7.00 per share

  • Published on 04/28/2026 at 19:53, 9 hours 15 minutes ago

    EQS-Adhoc: Scout24 SE resolves to launch a second tranche of its share buy-back programme of up to EUR 250 million in 2026 and to shorten the buy-back period of the ongoing tranche

  • Published on 04/28/2026 at 19:20, 9 hours 49 minutes ago

    CGTN: What China's strong start to the 15th FYP period signals

View all EQS
Les Echos
  • Published on 04/28/2026 at 18:00, 11 hours 9 minutes ago

    LDC has received approval from the Competition and Markets Authority (CMA) for the acquisition of shares in Green Label

  • Published on 04/28/2026 at 18:00, 11 hours 9 minutes ago

    LDC obtient l'autorisation de la Competition and Markets Authority (CMA) pour l’opération d’achat d’actions de la Société Green Label

  • Published on 04/28/2026 at 17:57, 11 hours 12 minutes ago

    Peugeot Invest signe un accord de cession de sa participation dans Immobilière Dassault pour 75 M€

  • Published on 04/28/2026 at 17:57, 11 hours 12 minutes ago

    Peugeot Invest enters into an agreement to sell its stake in Immobilière Dassault for €75 million

  • Published on 04/28/2026 at 17:55, 11 hours 13 minutes ago

    WEB SA - ASSEMBLEE GENERALE ORDINAIRE DU 28/04/2026 - RESOLUTIONS

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy